
How will GLP-1s impact the market for diabetes stocks? Berstein weighs in
Investing.com - Diabetes technology stocks have seen investor worries all but "vanish" over the possible negative implications of the emergence of popular obesity drugs, although it remains to be seen if this is a "false sense of security", according to analysts at Bernstein.A 2023 test showing that Novo Nordisk (NYSE:NVO)’s Wegovy weight-loss medication not only helped people lose weight b ...